Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Geron to Present at the J.P. Morgan Healthcare Conference


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-01-02 22:30:50 -

MENLO PARK, Calif., January 2, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John A. Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 1:00 p.m. Pacific Time on Thursday,
January 10, at the 31st Annual J.P. Morgan Healthcare Conference in San
Francisco.

A live webcast of the audio and slide presentation, including Q&A session, will
be available at
 jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticke ...
Following the live presentation, the webcast will be archived and available for
replay at the same address for a period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat. For more information
about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com 
### This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Geron Corp. via Thomson Reuters ONE [HUG#1667881]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser